Pharmaniaga skids on govt plan to focus on Pfizer


A health worker displays the Covid-19 vaccines developed by China's Sinovac. - Xinhua

KUALA LUMPUR: Shares of Pharmaniaga fell to a low of 88.5 sen on Friday after the government said states will begin dispensing more Pfizer-BioNTech vaccines over Sinovac.

Pharmaniaga has the contract to deliver the Sinovac vaccines and the latest statement worried investors as it had plans to expand the output of the China vaccine later.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Pharmaniaga , Sinovac , Pfizer

   

Next In Business News

Ringgit ends lower on firmer US dollar index
Artroniq sells Penang property for RM1.8mil
Digital banks will not affect traditional banks in Malaysia
Dufu sees rise in global semiconductor sales and memory sector
MICCI, Penang work together to boost competitiveness in semiconductors, ports, trade
VSTECS appointed as the first Amazon Web Services distributor in Malaysia
Apple’s China iPhone shipments soar 12% in March after discounts
KLCI dips on profit taking, stays firmly above 1,600 level
Contentious content
Swedish central bank lowers key rate, sees two more cuts this year

Others Also Read